Publication Details

Pubmed30442946
Title: PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.
Year: 2018
DOI: https://doi.org/10.1038/s41418-018-0233-1
First Author: Beck
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
PARP3_HUMANGSK3B_HUMANBioGRIDdetails